• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美金刚与酒精联合使用对适度饮酒者的急性影响。

Acute effects of memantine in combination with alcohol in moderate drinkers.

作者信息

Bisaga Adam, Evans Suzette M

机构信息

Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, USA.

出版信息

Psychopharmacology (Berl). 2004 Feb;172(1):16-24. doi: 10.1007/s00213-003-1617-5. Epub 2003 Oct 3.

DOI:10.1007/s00213-003-1617-5
PMID:14530901
Abstract

RATIONALE

Alcohol effects in humans involve N-methyl- d-aspartate (NMDA) receptor-mediated glutamatergic neurotransmission. It has been proposed that NMDA receptor antagonists may be effective in the treatment of alcohol dependence.

OBJECTIVE

This study evaluated the acute effects of memantine, an NMDA receptor antagonist, on the subjective, physiological, and performance effects of alcohol in moderate (10-30 drinks per week) alcohol drinkers.

METHODS

Eighteen volunteers without alcohol dependence were tested using a double-blind design with three 3-day long inpatient phases separated by at least a 2-week wash-out period. Memantine (0, 15, and 30 mg) was administered 4 h before alcohol (1.5 g/l body water), which was given in four divided doses every 20 min.

RESULTS

Pretreatment with memantine attenuated the craving for alcohol before alcohol administration, but not after alcohol was given. Memantine increased the dissociative effects of alcohol, without altering its sedative, stimulant, and overall intoxicating effects. Memantine also did not affect alcohol-induced impairment in performance, physiological changes, or pharmacokinetics. Memantine increased subjective reports of dissociation, confusion, and stimulation, and impaired motor coordination on the balance task.

CONCLUSIONS

Memantine was well tolerated in combination with alcohol. The findings suggest that NMDA receptor neurotransmission may be involved in alcohol craving and alcohol-induced subjective dissociative effects.

摘要

理论依据

酒精对人类的影响涉及N-甲基-D-天冬氨酸(NMDA)受体介导的谷氨酸能神经传递。有人提出,NMDA受体拮抗剂可能对酒精依赖的治疗有效。

目的

本研究评估了NMDA受体拮抗剂美金刚对中度饮酒者(每周饮酒10 - 30次)饮酒后的主观、生理和行为影响的急性效应。

方法

18名无酒精依赖的志愿者采用双盲设计进行测试,分为三个为期3天的住院阶段,各阶段之间至少间隔2周的洗脱期。在饮酒(每千克体重1.5克酒精)前4小时给予美金刚(0、15和30毫克),酒精分四次给药,每次间隔20分钟。

结果

美金刚预处理可减轻饮酒前对酒精的渴望,但饮酒后则无此效果。美金刚增强了酒精的分离效应,但未改变其镇静、兴奋和整体中毒效应。美金刚也未影响酒精所致的行为损害、生理变化或药代动力学。美金刚增加了分离、困惑和兴奋的主观报告,并损害了平衡任务中的运动协调性。

结论

美金刚与酒精联合使用耐受性良好。研究结果表明,NMDA受体神经传递可能与酒精渴望及酒精所致的主观分离效应有关。

相似文献

1
Acute effects of memantine in combination with alcohol in moderate drinkers.美金刚与酒精联合使用对适度饮酒者的急性影响。
Psychopharmacology (Berl). 2004 Feb;172(1):16-24. doi: 10.1007/s00213-003-1617-5. Epub 2003 Oct 3.
2
A pilot double-blind treatment trial of memantine for alcohol dependence.美金刚用于酒精依赖的一项试点双盲治疗试验。
Alcohol Clin Exp Res. 2007 May;31(5):775-82. doi: 10.1111/j.1530-0277.2007.00360.x. Epub 2007 Mar 22.
3
N-methyl-D-aspartate receptor antagonism has differential effects on alcohol craving and drinking in heavy drinkers.N-甲基-D-天冬氨酸受体拮抗作用对酗酒者的酒精渴望及饮酒行为具有不同影响。
Alcohol Clin Exp Res. 2015 Feb;39(2):300-7. doi: 10.1111/acer.12619. Epub 2015 Feb 9.
4
Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients.美金刚对酒精依赖康复患者线索诱导的酒精渴望的影响。
Am J Psychiatry. 2007 Mar;164(3):519-23. doi: 10.1176/ajp.2007.164.3.519.
5
Behavioral effects of aminoadamantane class NMDA receptor antagonists on schedule-induced alcohol and self-administration of water in mice.氨基金刚烷类NMDA受体拮抗剂对小鼠定时诱导饮酒及水自我给药行为的影响。
Psychopharmacology (Berl). 2006 Sep;187(4):424-34. doi: 10.1007/s00213-006-0465-5. Epub 2006 Jul 12.
6
Acute interaction of baclofen in combination with alcohol in heavy social drinkers.巴氯芬与酒精在重度社交饮酒者中的急性相互作用。
Alcohol Clin Exp Res. 2009 Jan;33(1):19-30. doi: 10.1111/j.1530-0277.2008.00805.x. Epub 2008 Oct 6.
7
Administration of memantine during ethanol withdrawal in neonatal rats: effects on long-term ethanol-induced motor incoordination and cerebellar Purkinje cell loss.新生大鼠乙醇戒断期间给予美金刚:对长期乙醇诱导的运动不协调和小脑浦肯野细胞丢失的影响。
Alcohol Clin Exp Res. 2011 Feb;35(2):355-64. doi: 10.1111/j.1530-0277.2010.01351.x. Epub 2010 Nov 10.
8
NMDA antagonists inhibit the development of ethanol dependence in rats.N-甲基-D-天冬氨酸(NMDA)拮抗剂可抑制大鼠乙醇依赖的发展。
Pol J Pharmacol. 2001 Jan-Feb;53(1):47-50.
9
Evidence for alcohol anti-craving properties of memantine.美金刚具有酒精抗渴望特性的证据。
Eur J Pharmacol. 1996 Oct 31;314(3):R1-2. doi: 10.1016/s0014-2999(96)00670-x.
10
Ethanol-reinforced behaviour in the rat: effects of uncompetitive NMDA receptor antagonist, memantine.大鼠中乙醇强化行为:非竞争性 N-甲基-D-天冬氨酸受体拮抗剂美金刚的作用
Eur J Pharmacol. 1998 Aug 7;354(2-3):135-43. doi: 10.1016/s0014-2999(98)00442-7.

引用本文的文献

1
Predicting individual treatment response in alcohol use disorders: a reverse translational proof-of-concept study.预测酒精使用障碍的个体治疗反应:一项反向转化概念验证研究。
Transl Psychiatry. 2025 Jun 24;15(1):212. doi: 10.1038/s41398-025-03431-2.
2
Basic information about memantine and its treatment of Alzheimer's disease and other clinical applications.美金刚的基本信息及其对阿尔茨海默病的治疗和其他临床应用。
Ibrain. 2023 Jun 6;9(3):340-348. doi: 10.1002/ibra.12098. eCollection 2023 Fall.
3
Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review.

本文引用的文献

1
NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy.N-甲基-D-天冬氨酸受体拮抗作用与乙醇中毒信号:从酒精中毒风险到药物治疗
Ann N Y Acad Sci. 2003 Nov;1003:176-84. doi: 10.1196/annals.1300.010.
2
Characterization of the discriminative stimulus effects of N-methyl- D-aspartate ligands under different ethanol training conditions in the cynomolgus monkey ( Macaca fascicularis).食蟹猴(猕猴)在不同乙醇训练条件下N-甲基-D-天冬氨酸配体辨别刺激效应的特征分析
Psychopharmacology (Berl). 2002 Jul;162(3):273-81. doi: 10.1007/s00213-002-1086-2. Epub 2002 May 14.
3
Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol.
用于治疗酒精使用障碍的非适应证用药和研究性药物:一项批判性综述
Front Pharmacol. 2022 Oct 3;13:927703. doi: 10.3389/fphar.2022.927703. eCollection 2022.
4
A novel NMDA receptor-based intervention to suppress compulsion-like alcohol drinking.一种新型 NMDA 受体为基础的干预措施,以抑制强迫性饮酒。
Neuropharmacology. 2019 Oct;157:107681. doi: 10.1016/j.neuropharm.2019.107681. Epub 2019 Jun 25.
5
Add-On Memantine Treatment for Bipolar II Disorder Comorbid with Alcohol Dependence: A 12-Week Follow-Up Study.双相情感障碍 II 型合并酒精依赖的附加美金刚治疗:一项为期 12 周的随访研究。
Alcohol Clin Exp Res. 2018 Jun;42(6):1044-1050. doi: 10.1111/acer.13640. Epub 2018 May 17.
6
Medications for alcohol use disorders: An overview.酒精使用障碍的药物治疗:概述。
Pharmacol Ther. 2018 May;185:64-85. doi: 10.1016/j.pharmthera.2017.11.007. Epub 2017 Dec 2.
7
Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective.谷氨酸可塑性贯穿酒精使用障碍的发展过程:多回路视角
F1000Res. 2017 Mar 21;6:298. doi: 10.12688/f1000research.9609.1. eCollection 2017.
8
Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder.代谢型和离子型谷氨酸受体作为治疗酒精使用障碍的潜在靶点。
Neurosci Biobehav Rev. 2017 Jun;77:14-31. doi: 10.1016/j.neubiorev.2017.02.024. Epub 2017 Feb 24.
9
Do specific NMDA receptor subunits act as gateways for addictive behaviors?特定的N-甲基-D-天冬氨酸(NMDA)受体亚基是否充当成瘾行为的门户?
Genes Brain Behav. 2017 Jan;16(1):118-138. doi: 10.1111/gbb.12348. Epub 2016 Nov 18.
10
Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.用于治疗酒精使用障碍的药物研发:对动物和人类实验室模型预测价值的见解。
Addict Biol. 2017 May;22(3):581-615. doi: 10.1111/adb.12349. Epub 2016 Feb 1.
美加明改变酒精的药代动力学和强化作用。
Alcohol Clin Exp Res. 2002 Mar;26(3):326-31.
4
Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.纳曲酮可降低酒精依赖者对酒精的渴望及自我给药量,并激活下丘脑-垂体-肾上腺皮质轴。
Psychopharmacology (Berl). 2002 Feb;160(1):19-29. doi: 10.1007/s002130100919. Epub 2002 Jan 22.
5
The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.N-甲基-D-天冬氨酸(NMDA)拮抗剂美金刚可减轻人体阿片类物质身体依赖性的表现。
Psychopharmacology (Berl). 2001 Aug;157(1):1-10. doi: 10.1007/s002130100739.
6
The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner.N-甲基-D-天冬氨酸受体通道阻滞剂美金刚、MRZ 2/579及其他氨基烷基环己烷以非竞争性方式拮抗培养的HEK-293和N1E-115细胞系统中的5-HT(3)受体电流。
Neurosci Lett. 2001 Jun 22;306(1-2):81-4. doi: 10.1016/s0304-3940(01)01872-9.
7
Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review.口服尼古丁剂型对戒烟症状及烟瘾的影响:一项系统评价
Psychopharmacology (Berl). 2001 May;155(2):115-22. doi: 10.1007/s002130100712.
8
Ethanol drug discrimination in rats: substitution with GABA agonists and NMDA antagonists.大鼠中的乙醇药物辨别:用γ-氨基丁酸(GABA)激动剂和N-甲基-D-天冬氨酸(NMDA)拮抗剂替代
Behav Pharmacol. 1994 Aug;5(4 And 5):441-451.
9
Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders.NMDA受体拮抗剂在治疗酒精和物质使用障碍方面的治疗潜力。
Expert Opin Investig Drugs. 2000 Oct;9(10):2233-48. doi: 10.1517/13543784.9.10.2233.
10
5-HT(3) receptor function and potentiation by alcohols in frontal cortex neurons from transgenic mice overexpressing the receptor.5-羟色胺(3)受体功能以及酒精对过表达该受体的转基因小鼠额叶皮质神经元的增强作用。
Neuropharmacology. 2000 Sep;39(12):2346-51. doi: 10.1016/s0028-3908(00)00064-2.